Refractive Eyecare Refractive Eyecare
Refractive Eyecare

CURRENT | CLINICAL | COMPREHENSIVE

Articles



Alert: There Is More to the Retina than Sight

by | January 2012

Those of us who are clinicians rather than vision scientists tend to equate the retina with rods, cones, and sight through the visual cortex. We know, for example, that when a patient has had a stroke in the visual cortex, there will be a homonymous defect in the visual field. Most of us are comfortable that our knowledge of the visual pathways is adequate and complete—at least for clinical purposes.

Login or Register to read more



UPDATE Intracorneal Ring Segments for Keratoconus

by | January 2012

Intracorneal ring segments can reshape ectatic corneas, staving off the need for keratoplasty and making previously contact-lens-intolerant patients capable of contact lens or spectacle correction.

When it first occurred to me to use intracorneal ring segments in keratoconus patients, my thought was that since ring segments had been shown to flatten myopic corneas, they might do something similar in the more deformable keratoconic corneas.1

Login or Register to read more



Smartphones, Photons, and the Future of Eyecare

by | December 2011

Campbell_Robert_FI

It may just be that I’m growing older, but it seems as if the pace of technology-driven change in eyecare continues to accelerate. Over a 30-year span, I have observed transitions in cataract surgery, from intracapsular to extracapsular, to phacoemulsification to small incision surgery, and, most recently, to femtosecond-laser assisted cataract removal.

Login or Register to read more



Will Crosslinking Play a Major Role in Vision Correction? – A Conversation with David Muller

by | December 2011

wre1512-mulller-hmpg

In the United States, collagen crosslinking has been thought of largely as a means of halting progression in keratoconus and other corneal ectasias. But David Muller, PhD, who as CEO of Summit Technology was a major figure in bringing the excimer laser to market two decades ago, has a much larger vision. Now CEO of Avedro, Inc., which is sponsoring some of the FDA collagen crosslinking trials, Muller believes that crosslinking has the potential to play a major role in LASIK and to eventually become a noninvasive refractive procedure entirely on its own.

Login or Register to read more